Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
809.00    11.00 (1.38%)
Bid:
807.00
Ask:
808.00
Spread: 1.00 (0.124%)
Market Cap: £1.63b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

28 Oct 2025 07:00

RNS Number : 9978E
Dunelm Group plc
28 October 2025
Β 

28 October 2025

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS EXERCISING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

Β 

Dunelm Group plc (the "Company") has been notified of the following transactions on 27 October 2025:

1. Clo Moriarty, Chief Executive Officer, exercised 108,436 nil cost options over ordinary shares of one pence each in the Company. These options were granted to her on 1 October 2025 under the terms of the Dunelm Group 2014 Long Term Incentive Plan in connection with buy-out arrangements to compensate her for share awards forfeited upon leaving her former employer. Clo has sold 51,119 ordinary shares at a price of Β£11.48 per share to fund the tax and national insurance due in connection with this exercise.

2. Karen Witts, Chief Financial Officer, exercised 17,983 nil cost options over ordinary shares of one pence each in the Company. These options were granted to her on 27 October 2022 under the terms of the Dunelm Group 2014 Long Term Incentive Plan. Karen has sold 8,478 ordinary shares at a price of Β£11.44 per share to fund the tax and national insurance due in connection with this exercise.

Β 

For further information please contact:Β 

Β 

Dunelm Group plc

Luisa Wright/Simon Hockridge

Β 

Β 

InvestorRelations@dunelm.com

Β 

Β 

MHP Communications

Β 

Β 

Rachel Farrington/Charles Hirst

Β 

Β 

dunelm@mhpgroup.com

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Clodagh Moriarty

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Dunelm Group plc

b)

Β 

LEI

Β 

213800WCOWEI3T5DUV19

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of one pence eachΒ 

Β 

Β 

ISINGB00BICQ739

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of nil cost options under the Long-Term Incentive Plan

2. Sale of shares to fund income tax and national insurance liability on exercise of such award

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil

Exercise of options: 108,436

Β£11.48

Shares sold: 51,119

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

1. 108,436

2. 51 119

Β 

1. Nil

2. Β£11.48

Β 

e)

Β 

Date of the transaction

Β 

Β 

2025.10.27

f)

Β 

Place of the transaction

Β 

Β 

1. Outside a trading venue

2. London Stock Exchange (XLON)

Β 

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Karen Witts

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Dunelm Group plc

b)

Β 

LEI

Β 

213800WCOWEI3T5DUV19

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of one pence eachΒ 

Β 

Β 

ISINGB00BICQ739

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of nil cost options under the Long-Term Incentive Plan

2. Sale of shares to fund income tax and national insurance liability on exercise of such award

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil

Exercise of options: 17,983

Β£11.44

Shares sold: 8,478

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

1. 17,983

2. 8,478

Β 

Β 

1. Nil

2. Β£11.44

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

2025.10.27

f)

Β 

Place of the transaction

Β 

Β 

1. Outside a trading venue

2. London Stock Exchange (XLON)

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPKOBPABDDCKB
Date   Source Headline
31st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSTotal Voting Rights
23rd Nov 20207:00 amRNSShare incentive awards
17th Nov 20201:00 pmRNSResult of AGM
5th Nov 20207:00 amRNSUpdate on latest Coronavirus restrictions
30th Oct 20207:00 amRNSTotal Voting Rights
28th Oct 20207:00 amRNSImportant information relating to the AGM
15th Oct 20207:00 amRNSFirst quarter trading update
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Oct 20207:00 amRNSAnnual Financial Report
30th Sep 20207:00 amRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirector/PDMR Shareholding
10th Sep 20207:01 amRNSConfirmation of Board change
10th Sep 20207:00 amRNSFinal Results
1st Sep 20207:00 amRNSTrading Update
28th Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:00 amRNSTotal Voting Rights
15th Jul 20207:00 amRNSFourth Quarter Trading Update
30th Jun 20207:00 amRNSTotal Voting Rights
29th Jun 202010:15 amRNSHolding(s) in Company
15th Jun 202012:40 pmRNSHolding(s) in Company
9th Jun 20201:15 pmRNSHolding(s) in Company
29th May 20207:00 amRNSTotal Voting Rights
21st May 202012:23 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
16th Apr 20207:00 amRNSBusiness and liquidity update
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
7th Apr 20207:00 amRNSBlock listing Interim Review
31st Mar 20207:00 amRNSTotal Voting Rights
24th Mar 20207:00 amRNSUpdate on current trading and Coronavirus
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 202012:45 pmRNSTotal Voting Rights
12th Feb 20205:41 pmRNSHolding(s) in Company
12th Feb 20207:00 amRNSInterim Results
31st Jan 20207:00 amRNSTotal Voting Rights
9th Jan 20207:00 amRNSSecond Quarter Trading Update
2nd Jan 202011:05 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
17th Dec 20199:00 amRNSHolding(s) in Company
10th Dec 20197:00 amRNSAppointment of joint corporate broker
5th Dec 20198:20 amRNSHolding(s) in Company
5th Dec 20197:00 amRNSTrading Update
29th Nov 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.